Consulting

    Besides training, our trainers are also available for consulting sessions in their respective fields. For more information, please get in touch using the form below.

    Drug Development

    Dr. Paula Muniz – Bioequivalence, IVIVC
    Dr. Helge NeidhardtCMC
    Franz Nothelfer – Viral Safety
    Dr. Malcolm Ross – Dissolution

    Process Scale-up, Validation & Technology Transfer

    Dr. Michael Braun – Solid Dosage
    Dr. Samuel Denby – Biologics
    Dr. Laura Butafoco – Injectables
    Jan Harmsen – Industrial processes

    Pharmaceutical Quality

    Dr. Tony Cundel – Stability, Microbial Testing – Biologics
    Dr. Malcolm Ross – Stability, Shelf-life – Solid Dosage

    Regulatory, Clinical Trials & Market Access

    Dr. Helge Neidhardt – CMC
    Dr. Simon Day – Orphan Drugs Clinical Trials
    Dr. Karl-Heinz Huemer – Paediatrics
    David Schwicker – Orphan Drugs Market Access
    Dr. Malcolm Ross – Value Added Medicines

    Orphan Drugs Strategy

    David Schwicker– Clinical Development, Regulatory, Market Access and Patient Centricity
    Dr. Simon Day– Orphan Drugs Clinical Trials, Biostatistics

    Basket